6 Third Avenue Management Supernus Pharmaceuticals Trades
Third Avenue Management acquired 189 Thousand Supernus Pharmaceuticals shares worth $6.01 Million. That's 1.18% of their equity portfolio (30th largest holding). The stake costed the investor $5.85 Million, netting the investor a gain of 2.8% so far.
News about Supernus Pharmaceuticals Inc and Third Avenue Management
New York Life Investment Management LLC Lowers Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
New York Life Investment Management LLC decreased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 25.5% during the first quarter, ...
Mitsubishi UFJ Asset Management UK Ltd. Buys New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Mitsubishi UFJ Asset Management UK Ltd. acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) in the third quarter, according to the company i...
Radcliffe Capital Management, L.P. Buys Supernus Pharmaceuticals Inc, BlackRock Capital ...
Related Stocks: DHHC , GFX , VYGG , SUPN , BKCC , DISH , INVA , GSBD , SIERU , GACQU , CENH , GIWWU , CAP , DEH , MAAC ,